Medcrypt Broadens Strategic Partnerships to Strengthen
Medical Device Cybersecurity Ecosystem Collaborations with BioT,
Extra Security, RTI, and Stratigos Security empower medical device
manufacturers with comprehensive cybersecurity solutions, including
cryptography, vulnerability management, penetration testing, and
FDA compliance support. Together, these partnerships provide
enhanced protection across device connectivity, threat detection,
and regulatory alignment, meeting the healthcare industry's growing
demand for secure, interoperable technology.
SAN
DIEGO, Nov. 12, 2024 /PRNewswire/ -- Medcrypt,
the leader in proactive security solutions for medical devices,
today announced an expansion of its strategic partnerships with
BioT, Extra Security, Real-Time Innovations (RTI), and Stratigos
Security. This collaborative network aims to deliver an enhanced
suite of cybersecurity capabilities, addressing the demand for
secure, interoperable technology solutions across the medical
device ecosystem.
BioT is the infrastructure for medical device clouds
– the secure, simple, and smart foundation for delivering
next-generation care. BioT extends Medcrypt's software
vulnerability capabilities into an analytic and operational
platform that executes a business-oriented plan specified for
impacted devices, use cases, and organizations, etc. BioT assesses
the relevance of what is actually deployed, mitigates
according to business risk, and provides proof of mitigation.
Extra Security, a leading cybersecurity consulting
firm, specializes in in-depth offensive security assessments
covering all aspects of medical devices and their supporting
systems. Extra Security provides high-fidelity, FDA-focused
security evaluations to Medcrypt customers, supporting FDA
submission requirements and strengthening ongoing security
programs. This partnership safeguards critical healthcare
technologies against evolving cyber threats, ensuring that
cybersecurity remains adaptive to the latest risks.
RTI, the leading provider of connectivity
software for autonomous systems, enables developers of complex
medical technologies—such as surgical robots and patient monitoring
devices—to incorporate Medcrypt's cybersecurity solutions alongside
RTI Connext® Security Extensions. This comprehensive,
out-of-the-box solution integrates encryption, authentication, and
secure communications, providing essential protections while
maintaining device performance and supporting compliance.
Stratigos Security, a trusted partner within
Medcrypt's network, plays an essential role in delivering technical
cybersecurity solutions with a regulatory focus for the medical
device industry. Specializing in penetration testing, vulnerability
assessments, and threat modeling, Stratigos Security helps
manufacturers integrate robust security measures throughout the
device lifecycle. Their approach ensures clarity and alignment for
engineers, regulatory affairs teams, and regulators, all working
toward achieving comprehensive regulatory readiness in today's
complex compliance landscape.
"By expanding our partnerships with BioT, Extra Security, RTI
and Stratigos Security, we can deliver a complete cybersecurity
ecosystem tailored to the unique needs of healthcare technology,"
said Om Mahida, Vice President of Product Management at Medcrypt.
"These collaborations equip our clients with end-to-end security,
from connectivity and compliance to threat detection and regulatory
strategy, helping them navigate the complex cybersecurity landscape
confidently."
Medcrypt and its partners will engage in joint marketing,
co-develop integration demonstrations, and raise industry awareness
of the critical importance of cybersecurity in medical devices.
Training exchanges between the teams will enhance their expertise,
ensuring all parties continue to evolve their solutions in response
to cybersecurity's unique demands within healthcare.
About MedCrypt
Medcrypt is helping healthcare technology companies ensure
medical devices are secure by design. We provide cybersecurity
products and strategic management consulting to expedite the
go-to-market process of medical device manufacturers' new
life-saving connected technologies. Founded in 2016 by a team of
healthcare cybersecurity experts, Medcrypt is uniquely positioned
to be the security catalyst for medical device manufacturers to
design secure, FDA-approved technologies. We continue to work with
those paving the way toward safe and reliable medtech.
To date, Medcrypt has raised more than $36 million in funding with participation from
Johnson & Johnson Innovations, Intuitive Ventures, and Dexcom
Ventures. For more information, please visit www.Medcrypt.com.
Press Contact:
Jenny Bourne
2087618447
http://www.medcrypt.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medcrypt-expands-strategic-partnerships-with-biot-extra-security-rti-and-stratigos-security-to-enhance-cybersecurity-in-medical-devices-302303541.html
SOURCE MedCrypt